Download PDF
Krankenhaushygiene up2date 2015; 10(02): 93-103
DOI: 10.1055/s-0034-1392253
Nosokomiale Infektionen
© Georg Thieme Verlag KG Stuttgart · New York

Häufung von RSV-Erkrankungen in einer hämato-onkologischen Abteilung[*]

Erkenntnisse einer epidemiologischen Ausbruchsuntersuchung
Elisabeth Aichinger
,
Udo Buchholz
Further Information

Publication History

Publication Date:
31 July 2015 (online)

Also available at
    Permissions and Reprints All articles of this category
Kernaussagen

Nosokomiale Ausbrüche von Erkrankungen mit respiratorischen Viren können insbesondere bei immungeschwächten Patienten auf hämato-onkologischen Stationen in schweren Fällen auch zu Pneumonien mit Todesfolge führen. Deshalb gibt es von der KRINKO spezielle Empfehlungen für diese Patientengruppe („Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten“). Anhand eines Ausbruchsgeschehens in einer süddeutschen Klinik wurden in einer Kohorten- und Fallkontrollstudie die Bedingungen genauer analysiert, die zum nosokomialen Ausbruch von RSV-Erkrankungen (respiratorische Synzytialviren) geführt hat. Aus den Ergebnissen wurden entsprechende Empfehlungen zu Ausbruchsprävention und -management abgeleitet.

* Dieser Artikel basiert zu Teilen auf der Veröffentlichung „Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit“ erschienen im PLOS Currents Outbreaks im September 2014.


 

  • Literatur

  • 1 Ison MG. Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation. Curr Opin Oncology 2009; 21: 171-176
    Google Scholar
  • 2 Renaud C, Campbell AP. Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients, in NIH Public Access 2011. PMC 2011; 333-343
    Google Scholar
  • 3 Falsey AR, Hennessey PA, Formica MA et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352: 1749-1759
    CrossrefPubMedGoogle Scholar
  • 4 Machado AF, Sallum MA, Vilas Boas LS et al. Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection?. Biol Blood Marrow Transplant 2008; 14: 1348-1355
    CrossrefGoogle Scholar
  • 5 Lessler J, Reich NG, Brookmeyer R et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009; 9: 291-300
    CrossrefGoogle Scholar
  • 6 Robert-Koch-Institut. Respiratorische Synzytial-Viren (RSV) – RKI-Ratgeber für Ärzte 2011. Robert-Koch-Institut. www.rki.de
    Google Scholar
  • 7 Weigl J, Puppe W, Schmitt H. Seasonality of respiratory syncytial virus-positive hospitalizations in children in Kiel, Germany, over a 7-year period. Infection 2002; 30: 186-192
    CrossrefGoogle Scholar
  • 8 Meerhoff TJ, Fleming D, Smith A et al. Surveillance recommendations based on an explanatory analysis of respiratory syncytial virus reports derived from the European Influenza Surveillance System. BMC Infect Dis 2006; 6: 128
    CrossrefGoogle Scholar
  • 9 Hall CB. Nosocomial respiratory syncytial virus infections: The “Cold War” has not ended. Clinl Infect Dis 2000; 31: 590-596
    Google Scholar
  • 10 Kassis C, Champlin RE, Hachem RY et al. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant 2010; 16: 1265-1271
    CrossrefGoogle Scholar
  • 11 Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008; 143: 455-467
    Google Scholar
  • 12 Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 2011; 117: 2755-2763
    CrossrefPubMedGoogle Scholar
  • 13 Khanna N, Widmer AF, Decker M et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 2008; 46: 402-412
    CrossrefPubMedGoogle Scholar
  • 14 Jones BL, Clark S, Curran ET et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromized adults. J Hospital Infect 2000; 44: 53-57
    CrossrefGoogle Scholar
  • 15 Lavergne V, Ghannoum M, Weiss K et al. Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program. Bone Marrow Transplant 2011; 46: 137-142
    CrossrefGoogle Scholar
  • 16 Jalal H, Bibby DF, Bennett J et al. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit. J Clin Microbiol 2007; 45: 1690-1696
    CrossrefGoogle Scholar
  • 17 Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Review). Cochrane Database Syst Rev 2007; 1
    Google Scholar
  • 18 Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000; 18-21
    Google Scholar
  • 19 Robert Koch-Institut. Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten Patienten- Empfehlungen der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Bundesgesundheitsblatt 2010; 53: 357-388
    Google Scholar
  • 20 Hirsch H, Boeckh M, Einsele H. Fourth European conference on infections in leukaemia (ECIL-4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 2013; 56: 258-266
    CrossrefGoogle Scholar